Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Fortschrittliche pharmazeutische Formulierung für gezielte therapeutische Intervention.
Dosierung
Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Stärke
Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Packungsgröße
Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Form
Dificlir-EMEA-H-C-2087-PSUV-0015: EPAR - Scientific conclusions and grounds recommending the variation to the terms of the marketing authorisation
Quelle
European Medicines Agency
